Published: May 15th 2024 | Updated: May 20th 2024
Minimizing the carbon footprint of ophthalmic surgeries
Published: July 22nd 2024 | Updated: July 27th 2024
ASRS 2024: Safety and durability of voretigene neparvovec-rzyl for biallelic RPE65
Published: July 19th 2024 | Updated: July 27th 2024
ASRS 2024: Neurotech Pharmaceuticals update on the NT-501 device
Published: July 24th 2024 | Updated: July 27th 2024
Eyenovia, Inc. and Senju Pharmaceutical Co., Ltd. sign new collaboration agreement
Published: July 19th 2024 | Updated: July 27th 2024
ASRS 2024: Update on the phase 2 DAVIO 2 trial
Published: January 6th 2021 | Updated: July 27th 2024
Thinking and rethinking ophthalmology: Are you?